Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Characteristics of COVID-19 in Patients With Pre-existing Cirrhosis (COVID-Cirrhosis-CHESS2002): A Multicentre Observational Study

NCT04329559 is registered in ClinicalTrials.gov with Hepatopancreatobiliary Surgery Institute of Gansu Province as lead sponsor.

NCT NCT04329559
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04329559 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Characteristics of COVID-19 in Patients With Pre-existing Cirrhosis (COVID-Cirrhosis-CHESS2002): A Multicentre Observational Study
Lead sponsor
Hepatopancreatobiliary Surgery Institute of Gansu Province
Phase
Observational
Overall status
Completed
Start date
March 30, 2020
Completion date
February 10, 2021
Enrollment
21 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, liver cirrhosis